A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2002
10/30/2002	CN1377346A Z-pyrazoline-5-ones
10/30/2002	CN1377344A Inhibitor of cysteinyl aspartic acid proteinase
10/30/2002	CN1377278A Prevention and treatment of amyloidogenic disease
10/30/2002	CN1377277A Use of leptin in inhibition of endothelial cell proliferation
10/30/2002	CN1377271A Use of thienopyrimidines
10/30/2002	CN1377268A Cell adhesion inhibitors
10/30/2002	CN1377267A Retard form containing 2-lipoic acid (derivatives)
10/30/2002	CN1377266A Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
10/30/2002	CN1377260A Methods and compounds for inhibiting amyloid deposits
10/30/2002	CN1377259A ACE-2 inhibiting compounds and methods of use thereof
10/30/2002	CN1377253A Stable hydrogenated lupulone antibacterial oral compositions
10/30/2002	CN1377252A Composition for restoring defects in calcified tissues
10/30/2002	CN1377235A Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions
10/30/2002	CN1376519A Multi-enzyme complex capsule
10/30/2002	CN1376518A Stable lactase composition
10/30/2002	CN1376505A Composite medicine for moistening intestine, relaxing bowels and nourishing skin
10/30/2002	CN1376493A Exterior-applied plaster for treating appendicitis and its preparing process
10/30/2002	CN1376492A Medicine for treating recurrent aphtha and eczema
10/30/2002	CN1376489A Chinese medicine for treating ulcerative colitis and its preparing process
10/30/2002	CN1376480A Oral liquid
10/30/2002	CN1376479A Yigandidu Dan for treating hepatitis B
10/30/2002	CN1093421C Process for preparing snuff to treat hepatitis B
10/30/2002	CN1093420C Process for preparing snuff to treat hepatitis A
10/30/2002	CN1093419C Sobering-up tea
10/30/2002	CN1093418C Mongolian medicine for treating gastrointestinal disease
10/30/2002	CN1093412C Chinese medicine for curing lithiasis
10/30/2002	CN1093403C Double regulation nutrient health-care product and its preparation method
10/30/2002	CN1093402C Gastritis treating tablet
10/30/2002	CA2383469A1 Treatment of t-cell mediated diseases
10/29/2002	US6472418 Non-peptide NK1 receptors antagonists
10/29/2002	US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002	US6472401 Administering an antiallergen of loratadine or metabolite of loratadine, desloratadine; migraines, stroke, orthostatic hypotension, gastrointestinal stasis, nausea, dizziness and jet lag; also psychological disorders; 5-ht7 receptors
10/29/2002	US6472390 Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
10/29/2002	US6472378 Compositions and methods for treatment of mitochondrial diseases
10/29/2002	US6472200 In vivo organ architecture (organ structure) of organ units (e.g., acinus of liver) is maintained within each indivisual micro-organ culture and the cultures being loacted within the chamber, in contact with fluid flowing through chamber
10/29/2002	US6471997 Antagonist of calcitonin gene related peptide, cgrp and/or of substance p; cosmetic
10/29/2002	US6471970 Use of pharmaceutical compositions capable of being gelled in periodontology
10/29/2002	US6471959 Human transferase
10/29/2002	US6471955 Polystyrenes as preferential time-release agents or carriers of prostaglandins such as misoprostol used for prevention of peptic ulcers
10/29/2002	US6471946 Oral composition
10/29/2002	CA2138683C Semi-paste oral preparations
10/25/2002	WO2001083451A1 Novel bicyclic compounds
10/24/2002	WO2002084249A2 Therapeutic and diagnostic uses of antibody specificity profiles
10/24/2002	WO2002083926A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/24/2002	WO2002083879A2 Immunotherapy based on dendritic cells
10/24/2002	WO2002083873A2 Enzymes
10/24/2002	WO2002083870A2 Pufa polyketide synthase systems and uses thereof
10/24/2002	WO2002083736A2 G-protein coupled receptor molecules and uses thereof
10/24/2002	WO2002083709A2 Kinases and phosphatases
10/24/2002	WO2002083704A1 Vascular endothelial growth factor 2
10/24/2002	WO2002083700A2 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
10/24/2002	WO2002083696A2 Novel cyclo azaphospha hydrocarbons
10/24/2002	WO2002083680A1 Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
10/24/2002	WO2002083668A1 Isoxaxole derivatives as inhibitors of src and other protein kinases
10/24/2002	WO2002083667A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002	WO2002083666A1 Substituted benzofuran-2-carboxamides derivatives
10/24/2002	WO2002083665A1 DIHYDRO-BENZO[b][1,4]DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I
10/24/2002	WO2002083664A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002	WO2002083663A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002	WO2002083658A1 Piperazine-benzamide derivatives useful as apob-100 and/or mtp inhibitor
10/24/2002	WO2002083645A1 Novel compounds
10/24/2002	WO2002083643A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
10/24/2002	WO2002083642A1 Compounds useful as anti-inflammatory agents
10/24/2002	WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002	WO2002083627A2 Ligands des integrins avss6
10/24/2002	WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002	WO2002083166A1 Interferon-polymer complexes and medicinal use thereof
10/24/2002	WO2002083147A1 Use of bile acid or bile salt fatty acid conjugates
10/24/2002	WO2002083143A1 Cxcr3 antagonists
10/24/2002	WO2002083128A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method
10/24/2002	WO2002083122A1 Fatty alcohols and fatty acid esters useful for treatment of inflammation
10/24/2002	WO2002083074A2 Methods for the treatment of hepatic disorders
10/24/2002	WO2002083060A2 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
10/24/2002	WO2002060931A3 A fimbria-like gene in bifidobacteria
10/24/2002	WO2002057253A3 Isoindolyl and isoquinolinyl aroyl pyrrole compounds for the treatment of central nervous system disorders
10/24/2002	WO2002055522A3 Novel multi-ring organic compounds for regulating gut motility and food intake
10/24/2002	WO2002051848A3 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
10/24/2002	WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002	WO2002026258A3 Treatment of immune-mediated diseases by oral administration of plasma fractions
10/24/2002	WO2002024659A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antgonists
10/24/2002	WO2001076568B1 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
10/24/2002	WO2001068135A9 Compositions and methods for affecting osteogenesis
10/24/2002	WO2001055337A3 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/24/2002	WO2000040247A9 2-oxy-benzoxazinone derivatives for the treatment of obesity
10/24/2002	US20020157121 Propagation of human hepatocytes in non-human animals
10/24/2002	US20020156284 Crystalline form of omeprazole
10/24/2002	US20020156266 Sodium phosphate cotransporter expressed on apical surface of intestinal epithelial cells (huNpt2B) and polypeptides related thereto
10/24/2002	US20020156264 And method of using the carboxypeptidase polypeptides and polynucleotides as a target for diagnosis and treatment in carboxypeptidase-related disorders
10/24/2002	US20020156254 Nucleotide sequences coding polypeptide for use in the treatment of stress, diabetes, cancer, inflammatory and cardiovascular disorders
10/24/2002	US20020156122 Statins (HMG-CoA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
10/24/2002	US20020156111 Substituted bicyclic compounds
10/24/2002	US20020156104 Novel pyrazole and pyrazoline substituted compounds
10/24/2002	US20020156102 Piperidine amides as modulators of chemo kine receptor activity
10/24/2002	US20020156089 Use of CRF antagonists and related compositions
10/24/2002	US20020156081 Pyrazolopyrimidines as therapeutic agents
10/24/2002	US20020156079 Antiulcer, antibacterial activity against Helicobacter pylori
10/24/2002	US20020156069 Benzo thiadiazine matrix metalloproteinase inhibitors
10/24/2002	US20020156061 Administering to a mammal a matrix metalloproteinase inhibiting amount of derivatives of isophthalic acid, isophthalic acid ester or isothalamide compounds to treat cancer, rheumatic arthritis atherosclerosis and osteoporosis
10/24/2002	US20020156053 Treating gastro-oesophageal reflux disease
10/24/2002	US20020156050 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors

1 ... 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 ... 1258